JAK Inhibitors Associated with Aggressive Lymphoma

JAK Inhibitors Associated with Aggressive Lymphoma

June 15, 2018 Study suggests screening patients to prevent second malignancy WASHINGTON, June 15, 2018 /PRNewswire/ — Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.